Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy
Open Access
- 16 July 2004
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 20 (2), 187-192
- https://doi.org/10.1002/jmri.20093
Abstract
Purpose To determine if short echo time (TE) 1H magnetic resonance spectroscopy (MRS) can distinguish between intracranial metastases and glioblastomas. Materials and Methods TE 30-msec spectra were acquired (1.5 T) from voxels entirely within tumors from 23 glioblastoma patients and 24 metastases patients (3 breast carcinomas, 1 bladder carcinoma, 8 lung carcinomas, 3 probable lung carcinomas, 6 melanomas, 1 stomach carcinoma, and 2 undetermined). Spectra were analyzed quantitatively (LCModel) to determine metabolite, lipid, and macromolecule concentrations. All tumors were previously untreated and classified histopathologically. Results The lipid peak area (LPA) ratio (total peak area at ca. δ1.3 to that at ca. δ0.9) was 2.6 ± 0.6 (N = 25) for glioblastomas and 3.8 ± 1.4 (N = 34) for metastases (P < 0.0001). There were no significant differences in metabolite or lipid concentrations between the tumor groups. The LPA ratio provided 80% sensitivity and 80% specificity for discriminating metastases from glioblastomas. Conclusion Lipid and macromolecule (LM) signals can dominate 1H spectra of high-grade tumors and have characteristics that allow significant discrimination of metastases from glioblastomas. Work is now needed to determine the source and biophysical characteristics of these LM signals to further improve differentiation by optimizing the data acquisition and analysis protocol. J. Magn. Reson. Imaging 2004;20:187–192.Keywords
This publication has 24 references indexed in Scilit:
- Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2003
- Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopyNeuro-Oncology, 2000
- Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopyNeuro-Oncology, 2000
- Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumorsJournal of Neurosurgery, 1999
- Automated classification of human brain tumours by neural network analysis using in vivo H magnetic resonance spectroscopic metabolite phenotypesNeuroReport, 1996
- Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter studyJournal of Neurosurgery, 1996
- Complications of CT-guided stereotactic biopsy of intra-axial brain lesionsJournal of Neurosurgery, 1994
- 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissueNMR in Biomedicine, 1994
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- 1H magnetic resonance of human tumours. Analysis of the transverse relaxation of the methylene protons using continuous distributions of relaxation timesNMR in Biomedicine, 1989